Maze Therapeutics, Inc. (MAZE) › RevenueMaze Therapeutics, Inc. (MAZE) — RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearRevenueChange YoY2024$167.50M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share